Cure My Disease

Don't miss your cure!

 Log in / Sign up

Pre-Exercise drink may shield teens with diabetes from dangerous sugar drops

NCT ID NCT05540132

Symptom relief Sponsor: State University of New York at Buffalo Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled This study
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study aimed to see if a corn-starch based drink taken before exercise could lower the risk of delayed low blood sugar in teens with type 1 diabetes. It also looked at whether it could improve biking performance. The study was withdrawn before enrolling any participants, so no results are available.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Started

Jul 2023

Expected to finish

Oct 2025

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

12 to 17 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age 12 - \<18 year old male and female subjects with Type 1 diabetes for \> 1 year * HbA1c \<10.5% * Body Mass Index \>10th % and \<95th% * Not being treated with sensor-augmented pump therapy * Ability to participate in exercise activity - biking * Willing to wear a continuous glucose monitor (CGM) sensor Exclusion Criteria: * Severe hypoglycemia (requiring glucagon or external assistance) in last 6 months * Admission for diabetic ketoacidosis in last 3 months * History of chronic lung disease, congenital heart disease or chronic asthma * Food (including corn)/dye allergies * Other chronic medical conditions except for well-controlled thyroid disease

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Hypoglycemia are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Motor Activity type 1 diabetes mellitus hypoglycemia prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Hypoglycemia Type 1 diabetes

Contacts and locations

Locations

  • UB MD Pediatrics Division of Pediatric Endocrinology

    Buffalo, New York, 14203, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.